Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Mutti · SciRah

Researcher profile · Semantic Scholar

L. Mutti

Share profile

L. Mutti — researcher profile on SciRah

h-index: 44
Works: 206
Citations: 6,444

Most-cited papers

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
I. Opitz, A. Scherpereel, T. Berghmans, I. Psallidas +26 more
2020European Journal of Cardio-Thoracic Surgery218 citations Open access
Semantic Scholar
Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells
M. Fiorillo, R. Lamb, H. Tanowitz, L. Mutti +5 more
2016OncoTarget205 citations Open access
Semantic Scholar
Scientific Advances and New Frontiers in Mesothelioma Therapeutics
L. Mutti, T. Peikert, B. Robinson, A. Scherpereel +10 more
2018Journal of Thoracic Oncology95 citations Open access
Semantic Scholar
HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy
P. Correale, L. Mutti, F. Pentimalli, Giovanni Baglio +3 more
2020International Journal of Molecular Sciences94 citations Open access
Semantic Scholar
Targeting hypoxic response for cancer therapy
E. Paolicchi, Federica Gemignani, M. Krstic-Demonacos, S. Dedhar +2 more
2016OncoTarget81 citations Open access
Semantic Scholar
The role of microenvironment and immunity in drug response in leukemia.
E. Bakker, M. Qattan, L. Mutti, C. Demonacos +1 more
2016Biochimica et Biophysica Acta79 citations Open access
Semantic Scholar
The function and clinical implication of YTHDF1 in the human system development and cancer
Wen-Jun Ren, Yi-Xiao Yuan, Yong-Wu Li, L. Mutti +2 more
2023Biomarker Research55 citations Open access
Semantic Scholar
Medical and surgical care of mesothelioma patients and their relatives carrying germline BAP1 mutations
M. Carbone, H. Pass, Guntulu Ak, H. Alexander +48 more
2022Journal of Thoracic Oncology55 citations Open access
Semantic Scholar
BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment
A. Guazzelli, Parisa Meysami, E. Bakker, C. Demonacos +3 more
2019International Journal of Molecular Sciences55 citations Open access
Semantic Scholar
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism
C. de Santi, O. Melaiu, A. Bonotti, L. Cascione +14 more
2017Scientific Reports55 citations Open access
Semantic Scholar
Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives
S. Gray, L. Mutti
2020Translational Lung Cancer Research53 citations Open access
Semantic Scholar
Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma
Tomer Meirson, F. Pentimalli, F. Cerza, Giovanni Baglio +7 more
2022JAMA Network Open52 citations Open access
Semantic Scholar
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis
P. Correale, R. Saladino, D. Giannarelli, Andrea Sergi +19 more
2020Cells49 citations Open access
Semantic Scholar
Expression and activity of eIF6 trigger Malignant Pleural Mesothelioma growth in vivo
A. Miluzio, S. Oliveto, E. Pesce, L. Mutti +5 more
2015OncoTarget41 citations Open access
Semantic Scholar
P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma
C. Costa, P. Indovina, E. Mattioli, I. Forte +10 more
2020Cell Death and Disease40 citations Open access
Semantic Scholar
Surgery for malignant pleural mesothelioma: an international guidelines review.
S. Ricciardi, G. Cardillo, C. Zirafa, F. Carleo +4 more
2018Journal of Thoracic Disease39 citations Open access
Semantic Scholar
CDK4, CDK6/cyclin-D1 Complex Inhibition and Radiotherapy for Cancer Control: A Role for Autophagy
V. Nardone, M. Barbarino, A. Angrisani, P. Correale +8 more
2021International Journal of Molecular Sciences36 citations Open access
Semantic Scholar
Immunotherapy beyond progression in patients with advanced non-small cell lung cancer
X. Ge, Zhi-Bo Zhang, Su-jie Zhang, Fang Yuan +15 more
2020Translational Lung Cancer Research36 citations Open access
Semantic Scholar
Expression status of candidate genes in mesothelioma tissues and cell lines.
O. Melaiu, E. Melissari, L. Mutti, E. Bracci +12 more
2015Mutation research36 citations Open access
Semantic Scholar
PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1
G. Pinton, A. G. Manente, B. Murer, E. Mariño +2 more
2013Journal of Cellular and Molecular Medicine35 citations Open access
Semantic Scholar
MSLN Gene Silencing Has an Anti-Malignant Effect on Cell Lines Overexpressing Mesothelin Deriving from Malignant Pleural Mesothelioma
O. Melaiu, J. Stebbing, Y. Lombardo, E. Bracci +9 more
2014PLoS ONE34 citations Open access
Semantic Scholar
A polysome-based microRNA screen identifies miR-24-3p as a novel pro-migratory miRNA in mesothelioma
S. Oliveto, R. Alfieri, A. Miluzio, A. Scagliola +6 more
2018Cancer Research31 citations Open access
Semantic Scholar
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review
V. Nardone, Caterina Romeo, E. d’Ippolito, P. Pastina +16 more
2023La radiologia medica29 citations Open access
Semantic Scholar
PRMT5 silencing selectively affects MTAP‐deleted mesothelioma: In vitro evidence of a novel promising approach
M. Barbarino, D. Césari, Maria Bottaro, L. Luzzi +13 more
2020Journal of Cellular and Molecular Medicine28 citations Open access
Semantic Scholar
European Respiratory Society guideline on various aspects of quality in lung cancer care
T. Blum, Rebecca L. Morgan, V. Durieux, J. Chorostowska-Wynimko +31 more
2022European Respiratory Journal27 citations Open access
Semantic Scholar
Tremelimumab for the treatment of malignant mesothelioma
A. Guazzelli, Michelle Hussain, M. Krstic-Demonacos, L. Mutti
2015Expert Opinion on Biological Therapy27 citations Open access
Semantic Scholar
Switching off malignant mesothelioma: exploiting the hypoxic microenvironment
Noushin Nabavi, K. Bennewith, A. Churg, Yu-Zhuo Wang +2 more
2016Genes & cancer26 citations Open access
Semantic Scholar
The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells
A. Pattarozzi, E. Carra, R. Favoni, Roberto Würth +6 more
2017Stem cell research & therapeutics25 citations Open access
Semantic Scholar
Preclinical Demonstration of Synergistic Active Nutrients/Drug (AND) Combination as a Potential Treatment for Malignant Pleural Mesothelioma
Viviana Volta, E. Ranzato, S. Martinotti, S. Gallo +4 more
2013PLoS ONE25 citations Open access
Semantic Scholar
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade
V. Nardone, R. Giannicola, G. Bianco, D. Giannarelli +11 more
2021Frontiers in Oncology23 citations Open access
Semantic Scholar
Anti-CTLA-4 therapy for malignant mesothelioma.
A. Guazzelli, E. Bakker, M. Krstic-Demonacos, M. Lisanti +2 more
2017Immunotherapy23 citations Open access
Semantic Scholar
Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
F. Morani, Luisa Bisceglia, Giulia Rosini, L. Mutti +3 more
2021International Journal of Molecular Sciences22 citations Open access
Semantic Scholar
Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)
Irene Dell'anno, E. Barone, L. Mutti, D. Rassl +4 more
2020Journal of Translational Medicine22 citations Open access
Semantic Scholar
A Common Polymorphism Within MSLN Affects miR-611 Binding Site and Soluble Mesothelin Levels in Healthy People
S. Garritano, C. de Santi, Roberto Silvestri, O. Melaiu +10 more
2014Journal of Thoracic Oncology21 citations Open access
Semantic Scholar
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines
O. Melaiu, Calogerina Catalano, C. de Santi, M. Cipollini +14 more
2017Genes & cancer20 citations Open access
Semantic Scholar
Sirtuin Family Members Selectively Regulate Autophagy in Osteosarcoma and Mesothelioma Cells in Response to Cellular Stress
Richa Garva, Chutamas Thepmalee, U. Yasamut, S. Sudsaward +10 more
2019Frontiers in Oncology19 citations Open access
Semantic Scholar
Coronavirus Disease (Covid-19): What Are We Learning in a Country With High Mortality Rate?
L. Mutti, F. Pentimalli, Giovanni Baglio, P. Maiorano +3 more
2020Frontiers in Immunology17 citations Open access
Semantic Scholar
Therapies currently in Phase II trials for malignant pleural mesothelioma
G. Pinton, A. G. Manente, Daniela Tavian, L. Moro +1 more
2013Expert Opinion on Investigational Drugs17 citations
Semantic Scholar
Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state
Rashed Alhammad, Sasiprapa Khunchai, Nopprarat Tongmuang, T. Limjindaporn +4 more
2020Oncology Report16 citations Open access
Semantic Scholar
Over-Expression of Long Non-Coding RNA-AC099850.3 Correlates With Tumor Progression and Poor Prognosis in Lung Adenocarcinoma
Xi Chen, Ji-Shu Guo, Fan Zhou, Wen-Jun Ren +4 more
2022Frontiers in Oncology15 citations Open access
Semantic Scholar
The function and clinical implication of circular RNAs in lung cancer
Wen-Jun Ren, Yi-Xiao Yuan, Jun Peng, L. Mutti +1 more
2022Frontiers in Oncology14 citations Open access
Semantic Scholar
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma
Irene Dell'anno, Alessandra Melani, S. Martin, M. Barbarino +9 more
2022Cancers14 citations Open access
Semantic Scholar
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?
A. Baird, D. Easty, M. Jarzabek, L. Shiels +23 more
2019Frontiers in Endocrinology14 citations Open access
Semantic Scholar
p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification
K. Tian, E. Bakker, Michelle Hussain, A. Guazzelli +6 more
2018Journal of Translational Medicine14 citations Open access
Semantic Scholar
Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma
A. Guazzelli, E. Bakker, K. Tian, C. Demonacos +2 more
2017Expert Opinion on Investigational Drugs14 citations Open access
Semantic Scholar
ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe
A. Rich, D. Baldwin, P. Beckett, T. Berghmans +24 more
2018European Respiratory Journal13 citations Open access
Semantic Scholar
Immunotherapy advances for mesothelioma treatment
E. Bakker, A. Guazzelli, F. Ashtiani, C. Demonacos +2 more
2017Expert Review of Anticancer Therapy13 citations Open access
Semantic Scholar
Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis
V. Nardone, R. Giannicola, D. Giannarelli, R. Saladino +20 more
2021Life11 citations Open access
Semantic Scholar
Insight into glucocorticoid receptor signalling through interactome model analysis
E. Bakker, K. Tian, L. Mutti, C. Demonacos +2 more
2017PLoS Comput. Biol.11 citations Open access
Semantic Scholar
Current and prospective pharmacotherapies for the treatment of pleural mesothelioma
E. Bakker, A. Guazzelli, M. Krstic-Demonacos, M. Lisanti +2 more
201711 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Krstic-Demonacos×14
Invite
M. Krstic-Demonacos — researcher profile on SciRah
A. Giordano×10
Invite
A. Giordano — researcher profile on SciRah
Federica Gemignani×9
Invite
Federica Gemignani — researcher profile on SciRah
S. Landi×9
Invite
S. Landi — researcher profile on SciRah

×9

Invite

A. Guazzelli — researcher profile on SciRah

Invite

P. Correale — researcher profile on SciRah

Invite

E. Bakker — researcher profile on SciRah

C. Demonacos×8

Invite

C. Demonacos — researcher profile on SciRah

Invite

O. Melaiu — researcher profile on SciRah

Invite

L. Pirtoli — researcher profile on SciRah

F. Pentimalli×5

Invite

F. Pentimalli — researcher profile on SciRah

Invite

A. Bonotti — researcher profile on SciRah